Initia Announces Strategic Partnership with Dr. Cobi Reisman in Tel Aviv

Tel Aviv-Yafo, Israel – August 5, 2024

Initia Announces Strategic Partnership with Dr. Cobi Reisman in Tel Aviv

Initia is proud to announce a new collaboration with Dr. Cobi Reisman, an internationally renowned expert in urology and sexual health. With extensive clinical experience in both Israel and the Netherlands, Dr. Reisman brings unparalleled expertise to our mission of advancing non-invasive, regenerative therapies.

A Leader in Sexual Health

Dr. Reisman is the founder of the European Training and Certification Program in Sexual Health and Sexual Therapy and a former President of the European Society for Sexual Medicine (ESSM). His career has been defined by leadership, innovation, and dedication to improving patient outcomes in the fields of urology and sexual health.

Partnership Focus: Expanding Clinical Applications of MoreNova®

Through this collaboration, Dr. Reisman will introduce the MoreNova® shockwave therapy system at his distinguished clinic in Tel Aviv-Yafo. He will lead clinical programs that apply the technology to a broad spectrum of conditions, including:

  • Men’s Health: Erectile Dysfunction (ED), Chronic Pelvic Pain Syndrome (CPPS) / Chronic Prostatitis (CP), Peyronie’s Disease (PD)
  • Women’s Health: Female Sexual Dysfunction (FSD), female sexual pain syndromes (including Vulvodynia)

By leveraging his deep clinical expertise, Dr. Reisman will help expand the evidence base for MoreNova® while pioneering new approaches to treatment in both men’s and women’s health.

Driving Innovation Together

This partnership marks an exciting step forward in Initia’s commitment to collaborating with global leaders in medicine. By working closely with Dr. Reisman, we aim to further validate the benefits of MoreNova® and broaden access to safe, effective, and non-invasive treatments for patients worldwide.

“Partnering with Dr. Reisman allows us to bring world-class expertise to our clinical initiatives and accelerate innovation in sexual health therapies,” said [Insert Spokesperson Name, Title].

We look forward to sharing updates on this collaboration and the clinical advancements it will bring in the months ahead.